"Tempus has an unwavering commitment to providing ... Clinicians can enhance molecular insights by adding xR RNA sequencing, xF/xF+ liquid biopsy, immunohistochemistry tests such as HER2 and ...

Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

Former House Speaker Nancy Pelosi discloses the purchase of 50 call options in Tempus AI with a strike price of $20. Tempus AI on Tuesday announced the national launch of its AI-enabled personal ...

In a report released today, Ryan MacDonald from Needham reiterated a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report), with a price target of $56.00. Discover outperforming stocks ...

In addition to the financial information presented in this release in accordance with accounting principles generally accepted in the United States of America (GAAP), Tempus also presents the non ...